Publication | Closed Access

Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy

Maternal Cardiovascular OutcomeReproductive HealthGynecologyMaternal HealthSimvastatin ExposureMaternal-fetal MedicinePublic HealthMedicineReproductive EpidemiologyEpidemiologyWomen's HealthHigh-risk Pregnancy